Sixty patients with severe pustular and cystic acne were treated for prolonged periods with clindamycin (150 mg to 300 mg daily). The average duration of therapy was five months, with 18 patients being treated for more than six months. Only two (3.4%) patients developed mild diarrhea, which was rapidly reversible on discontinuance of the drug. No other adverse reactions were observed. These data suggest that long-term, low-dose clindamycin therapy may be safe for severe pustular of cystic acne.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
clindamycin therapy
8
severe pustular
8
pustular cystic
8
cystic acne
8
safety long-term
4
long-term clindamycin
4
therapy acne
4
acne sixty
4
sixty patients
4
patients severe
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!